Cartesian Therapeutics
RNAC
RNAC
36 hedge funds and large institutions have $32.4M invested in Cartesian Therapeutics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
-8
Holders Change %
-18.18%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
7
Reduced
16
Closed
11
Calls
$53K
Puts
–
Net Calls
+$53K
Net Calls Change
+$57K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$285K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$44.7K |
| 3 |
HF
HRT Financial
New York
|
+$23K |
| 4 |
Two Sigma Investments
New York
|
+$20K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$15.9K |
Top Sellers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$977K |
| 2 |
FI
Fosun International
Hong Kong,
China
|
-$824K |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$758K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$524K |
| 5 |
Millennium Management
New York
|
-$253K |
